DJIA 17,113.54 61.81 0.36%
NASDAQ 4,456.02 31.31 0.71%
S&P 500 1,983.53 9.90 0.50%
market minute promo

Dendreon Corp (NASDAQ: DNDN)

2.10 -0.04 (-1.87%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

DNDN $2.10 -1.87%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.14
Previous Close $2.14
Daily Range $2.08 - $2.19
52-Week Range $1.81 - $5.38
Market Cap $335.9M
P/E Ratio -1.25
Dividend (Yield) $0.00 (0.0%)
Volume 1,532,906
Average Daily Volume 2,042,776
Current FY EPS -$0.77





Dendreon Corp (DNDN) Description

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. Website:

News & Commentary Rss Feed

These 5 Cancer Immunotherapy Companies All Have 1 Thing in Common

Cancer immunotherapies are all the rage on Wall Street, but these five immunotherapy-focused companies all have one big thing in common.

Why You Should Buy Dendreon's Drop

August 29th Options Now Available For Dendreon

Stocks To Watch Today: NQ Mobile, CBS, Seadrill...

Morning Market Movers

Benzinga's Top #PreMarket Gainers

New Provenge Data: Why Deerfield Investments Acquired A More Than 5% Stake In May

What Does Dendreon Need To Succeed?

Dendreon (DNDN) Stock Has Huge Short Interest: Time to Cover? - Tale of the Tape

Long Or Short: Cancer Cures

Dendreon May Still Be In Play

See More DNDN News...

DNDN's Top Competitors

DNDN $2.10 (-1.87%)
Current stock: DNDN
AMGN $121.11 (1.75%)
Current stock: AMGN
GILD $89.33 (0.53%)
Current stock: GILD
BIIB $303.67 (0.39%)
Current stock: BIIB